Answers are grounded in this paper and cite their sources.
Shows elevated daptomycin and linezolid inhibitory concentrations in pediatric methicillin-resistant staphylococci, suggesting potential risks of treatment failure.
We evaluated minimal inhibitory concentration (MIC) for vancomycin, daptomycin, and linezolid in methicillin-resistant coagulase-negative staphylococci (MR-CoNS). Minimal inhibitory concentration of 2-4 mg/l for vancomycin was observed in 16% of strains, and among them 19% had MIC at breakpoint for daptomycin or linezolid. Among strains completely susceptible to vancomycin, 16% had MIC at breakpoint for daptomycin and 11% had for linezolid. This large proportion of pathogens with MIC around the breakpoint suggests a possible risk of treatment failure with these drugs. This phenomenon is worth further and constant monitoring.
No takes yet. Share an insight, caveat, or question.
Castagnola et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: